Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Hemophilia A

Interventions

DRUG

FVIII

FVIII concentration 35-40 U/kg/dose 1 time/week for 5 months

DRUG

FVIII

FVIII concentration 15-20 U/kg/dose 1 time/week for 5 months

Trial Locations (1)

Division of Hemato/oncology, Department of Pediatrics, Faculty of medicine,Chulalongkorn U, Bangkok

All Listed Sponsors

lead

Chulalongkorn University

OTHER

NCT02727647 - Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients | Biotech Hunter | Biotech Hunter